Switzerland· 68130001
Kerendia
A finerenone product containing finerenonum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Finerenone is registered in 15 of 19 countries.
Countries holding a registration under ATC C03DA05 (finerenone), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 9 of them publish a price we can compare per daily dose
Finerenone · ATC C03DA05
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of finerenone costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- Switzerland: $4.82 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Finerenone · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- IT Italy$5.64
- CH Switzerland$4.82
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- finerenonum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- C03DA05
- ATC class
- Finerenone
- Defined daily dose
- 20 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680681300014Blist 28 StkCHF 61.8
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Finerenone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKERENDIABayer AG, Leverkusen
- FinlandKerendiaOrifarm Oy
- NetherlandsKerendia 10 mg filmomhulde tablettenBayer AG
- IrelandKerendia 10 mg Film-coated tabletBayer AG
- IcelandKerendiaBayer AG*
- NorwayKerendiaBayer AG
- PolandKerendiaBayer AG
- SwedenKerendia 10 mg Filmdragerad tablettBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kerendia
- Liechtenstein · Kerendia
- Norway · Kerendia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dbd49f29-d541-4748-bc46-f468620cc6dc GET /v1/drugs/dbd49f29-d541-4748-bc46-f468620cc6dc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "finerenonum 10 mg",
"valid_from": "2023-06-01",
"limitations": "[{\"description\":\"KERENDIA wird vergütet zur Verzögerung der Progression einer chronischen Nierenerkrankung bei erwachsenen Patienten mit Typ-2 Diabetes mellitus.<br>\\n<br>\\nKriterien für die Therapieeinleitung:<br> \\n•\\tSerumkaliumspiegel ≤ 5 mmol/l<br> \\n•\\tchronische Nierenerkrankung seit mindestens 3 Monaten<br> \\n•\\teGFR von 25-59 ml/min/1.73m<sup>2</sup> und einen Albumin-Kreatinin-Quotient im Urin von > 30 mg/g oder<br> \\n•\\teGFR von 25-75 ml/min/1.73m<sup>2</sup> und einen Albumin-Kreatinin-Quotient im Urin von > 300 mg/g<br>\\n•\\tVorbehandlung mit einer maximal verträglichen zugelassenen Dosis eines Angiotensin-Converting-Enzyme-Hemmers oder eines Angiotensinrezeptorblockers<br> \\n•\\tIn Kombination mit SGLT2-Inhibitoren nur bei Patienten mit eGFR von 25-59 ml/min/1.73m<sup>2</sup> und einen Albumin-Kreatinin-Quotient im Urin von > 300mg/g<br>\\n<br>\\n\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2023-06-01\",\"validTo\":null}]",
"galenic_form": "Filmtabl 10 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2023-06-01",
"self_retention_pct": 10
}See everything about finerenone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.